Description
ASPA Polyclonal Antibody | E-AB-10966 | Gentaur UK, US & Europe Distribution
Type: Polyclonal Antibody
Synonyms: ACY 2, ACY-2, ACY2, ACY2, Aminoacylase 2, Aminoacylase-2, Aminoacylase2, ASP, ASPA, Aspartoacylase (aminoacylase 2, Canavan disease), Aspartoacylase (Canavan disease), Aspartoacylase, NUR 7, NUR7, OTTMUSP00000006437, RP23-213I10.1, Small lethargic
Application: WB, IHC, ELISA
Reactivity: Human, Mouse, Rat
Host: Rabbit
Isotype: IgG
Reserch Areas: Cancer, Metabolism, Neuroscience, Signal Transduction
Background: This gene encodes an enzyme that catalyzes the conversion of N-acetyl_L-aspartic acid (NAA) to aspartate and acetate. NAA is abundant in the brain where hydrolysis by aspartoacylase is thought to help maintain white matter. This protein is an NAA scavenger in other tissues. Mutations in this gene cause Canavan disease. Alternatively spliced transcript variants have been found for this gene.
Concentration: 0.4 mg/mL
Storage: Store at -20°C. Avoid freeze / thaw cycles.
Immunogen: Recombinant protein of human ASPA
Buffer: PBS with 0.05% sodium azide and 50% glycerol, PH7.4
Purification Method: Affinity purification
Dilution: WB 1:1000-1:5000, IHC 1:100-1:300
Clone: N/A
Conjugation: Unconjugated
Molecular Weight(Calculated): 36 kDa
Molecular Weight(Observed): N/A